Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The company has a collaboration with Bayer for the research and development of evaluating potential future production of iodine to be used in contrast media drugs. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The company is headquartered in Calgary, Canada.
Frequently asked questions
What sector does Voyageur Pharmaceuticals Ltd (VM) operate in?
Voyageur Pharmaceuticals Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Voyageur Pharmaceuticals Ltd (VM) current stock price?
As of the latest data, Voyageur Pharmaceuticals Ltd stock price is CA$0.17, with a previous close of CA$0.17. Voyageur Pharmaceuticals Ltd gained CA$0.01 in the last trading session, representing a 3.03% increase.
What is Voyageur Pharmaceuticals Ltd (VM) current market capitalization?
Voyageur Pharmaceuticals Ltd market cap is approximately 30.51 million.
What is Voyageur Pharmaceuticals Ltd (VM) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.02.
Does Voyageur Pharmaceuticals Ltd (VM) pay dividends?
No. Voyageur Pharmaceuticals Ltd does not pay a dividend.
When is Voyageur Pharmaceuticals Ltd (VM) next earnings report?
Voyageur Pharmaceuticals Ltd is expected to release its next earnings report on May 31, 2026.
What is Voyageur Pharmaceuticals Ltd (VM) beta (volatility) score?
Voyageur Pharmaceuticals Ltd has a beta of 0.294, indicating lower volatility than the overall market.
